Alphyn Biologics
Clinical-stage dermatology co. developing first-in-class Multi-Target Therapeutics (MTT)
Based in MD
AI Overview
With $30K in lobbying spend across 3 quarterly filings, Alphyn Biologics is an active lobbying client. Their lobbying covers 2 issue areas.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2025 | $30K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Alphyn Biologics disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, MED
Issues related to the development of biologic therapies before Congress, the Food and Drug Administration (FDA), and other federal health agencies.
Advocacy work around Atopic Dermatitis (eczema).
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.